Patients with HCC are shown to have a relatively high serum level of IL-23 secreted by inflammatory macrophages, which promotes macrophage-mediated angiogenesis by positively regulating the expression of IL-23 receptors on macrophages and accelerates HCC progression resulting from chronic hepatitis virus infection (Zang et al., 2018). Here, IL23R is linked to hepatocellular carcinoma.